rifapentine
Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
rifamycin antibioticARO:3000157
-
CHEBI:26580 -
CHEBI:46845 -
CHEBI:46847 - rifamycin antibiotic
ARO:3000157
Chemical structure
| Molecular formula | C47H64N4O12 |
|---|---|
| Charge | 0 |
| Average mass | 877.045 Da |
| Monoisotopic mass | 876.45207 Da |
| Source | ChEBI |
| InChIKey | WDZCUPBHRAEYDL-GZAUEHORSA-N |
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1
Also called
- (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
- 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin
- Cyclopentylrifampicin
- Priftin (TN)
- Rifapentine
- priftin
Cross-references
- rifapentine
ARO:3000534 - cas:61379-65-5
- kegg.compound:C08059
- chembl:CHEMBL1660
- pubchem.compound:135403821
Drug registries
Patents and articles
Activity roles
- leprostatic drug
CHEBI:35816
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000534 |
rifapentine | antibioticmech:aro-541de42362 |
2026-08-30 |
| CHEBI | CHEBI:45304 |
rifapentine | antibioticmech:chebi-80097be7f3 |
2026-08-30 |
Molecular targets
rifamycin sensitive beta-subunit of RNA polymerase (rpoB) PROTEIN_COMPLEX DIRECT_BINDING_TARGET
Mechanism summary
- Clinical status
- APPROVED
Resistance mechanisms
ANTIBIOTIC_INACTIVATION 6
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Streptomyces venezuelae rox | ARO:3007209 | — | ||
| iri | ARO:3002884 | — | ||
| rgt1438 | ARO:3002883 | — | ||
| rifampin ADP-ribosyltransferase (Arr) | ARO:3000390 | — | ||
| rphA | ARO:3000444 | — | ||
| rphB | ARO:3003992 | — |
ANTIBIOTIC_TARGET_REPLACEMENT 5
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Escherichia coli rpoB mutants conferring resistance to rifampicin | ARO:3003288 | — | ||
| Mycobacterium leprae rpoB mutations conferring resistance to rifampicin | ARO:3003284 | — | ||
| Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin | ARO:3003283 | — | ||
| Staphylococcus aureus rpoB mutants conferring resistance to rifampicin | ARO:3003285 | — | ||
| rpoB2 | ARO:3000501 | — |
ANTIBIOTIC_TARGET_PROTECTION 3
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| DnaA | ARO:3000248 | — | ||
| RbpA | ARO:3000245 | — | ||
| sigma factor conferring resistance to rifampin | ARO:3000261 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories